Expressions of CD96 and CD123 in bone marrow cells of patients with myelodysplastic syndromes

Clinical Laboratory

Volumn 61, Issue 10, 2015, Pages 1429-1434

  Zhang, Wei ^a   Shao, Zonghong ^a   Fu, Rong ^a   Wang, Huaquan ^a   Li, Lijuan ^a   Liu, Hui ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

CD 123; CD96; Myelodysplastic syndromes

Indexed keywords

CD114 ANTIGEN; CD123 ANTIGEN; CD34 ANTIGEN; CD38 ANTIGEN; CD96 ANTIGEN; LIPOCORTIN 5; LYMPHOCYTE ANTIGEN; THROMBOPOIETIN RECEPTOR; UNCLASSIFIED DRUG; CYTOKINE; IL3RA PROTEIN, HUMAN; LEUKOCYTE ANTIGEN;

ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BONE MARROW CELL; CANCER STEM CELL; CONTROLLED STUDY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HIGH RISK POPULATION; HUMAN; HUMAN CELL; KARYOTYPE; LEUKEMIA STEM CELL; LOW RISK POPULATION; MALE; MYELODYSPLASTIC SYNDROME; PERIPHERAL BLOOD MONONUCLEAR CELL; BLOOD; CASE CONTROL STUDY; CELL SEPARATION; CYTOLOGY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; METABOLISM; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD; ANTIGENS, CD34; ANTIGENS, CD38; APOPTOSIS; BONE MARROW CELLS; CASE-CONTROL STUDIES; CELL SEPARATION; CYTOKINES; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-3 RECEPTOR ALPHA SUBUNIT; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; YOUNG ADULT;

EID: 84948390730     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: 10.7754/Clin.Lab.2015.141240     Document Type: Article

References (16)

1. Shi J, Shao ZH, Liu H, et al Transformation of myelodysplastic syndromes into acute myeloid leukemia. Chin Med J 2004; 117: 963-7.
2. Shao Z, Zhang H, Chen G., et al. Expression and function of c-kit receptor in bone marrow mononuclear cells of patients with myelodysplastic syndromes. Chin Med J 2001; 114:481-5.
3. Riccioni R, Rossini A, Calabrò L, et al. Immunophenotypic features of acute myeloid leukemias overexpressing the interleukin 3 receptor alpha chain. Leuk Lymphoma 2004; 45:1511-7.
4. Hosen N, Park CY, Tatsumi N, et al CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia. Proc Natl Acad Sci USA 2007; 104:11008-13.
5. Vardiman JW, Thiele J, Arber D.A., et al. The 2008 revision of the World Health Organization (WHO) classification of the myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009; 114:937-51.
6. + stem cells in vitro and in vivo: New avenues for autologous stem cell transplantation in acute myeloid leukemia. Oncoimmunology 2013; 2(6):e24500.
7. + cells in low-grade myelodysplastic syndromes. Blood 2006; 108:1037-44.
8. Ogata K, Delia Porta MG, Malcovati L, et al. Diagnostic utility of flow cytometry in low-grade myelodysplastic syndromes: a prospective validation study. Hematologica 2009; 94:1066-74.
9. Yilmaz Z, Sahin FI, Kizilkilic E, Karakus S., Boga C, Ozdogu H. Conventional and molecular cytogenetic findings of myelodysplastic syndrome patients. Clin Exp Med 2005; 5:55-9.
10. Valent P, Horny HP, Bennett J.M., et al. Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference. Leuk Res 2007; 31:727-36.
11. + cells in myelodysplastic syndrome displaying malignant features similar to those in AML. Int J Hematol 2014; 100(1):60-9.
12. - bone marrow cells in myelodysplastic syndromes. Cytometry A 2010; 77:840-8.
13. Graf M, Hecht K, Reif S., Pelka-Fleischer R, Pfister K, Schmetzer H. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies. Eur J Hematol 2004; 72:89-106.
14. Yue LZ, Fu R, Wang H.Q., et al. Expression of CD123 and CD114 on the bone marrow cells of patients with myelodysplastic syndrome. Chin Med J 2010; 123:2034-7.
15. Jelkmann W, Bohlius J, Hallek M., Sytkowski AJ. The erythropoietin receptor in normal and cancer tissues. Crit Rev Oncol-Hematol 2008; 67:39-61.
16. O'Sullivan L.A., Lionque C, Lewis R.S., Stephenson SE, Ward AC. Cytokine receptor signaling through the Jak-Stat-Socs pathway in disease. Mol Immunol 2007; 44:2497-506.